Jonathan Rhee, MD
Urology · Silver Spring, MDNPI 1952518979
Payments from drug & device makers
Across 56 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$244
- Procept Biorobotics Corporation$174
- Coloplast$101
- Endo USA, Inc.$100
- Antares Pharma, Inc.$93
- Boston Scientific$73
- plus $389 from 13 others
What the payments were for
- Food & beverage$1,16399%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 12 | $244 |
| Procept Biorobotics Corporation | 2 | $174 |
| Coloplast | 5 | $101 |
| Endo USA, Inc. | 4 | $100 |
| Antares Pharma, Inc. | 3 | $93 |
| Boston Scientific | 4 | $73 |
| Urogen Pharma, Inc. | 3 | $62 |
| 180 Medical, Inc. | 2 | $58 |
| Halozyme Inc | 2 | $46 |
| Intuitive Surgical | 1 | $40 |
| AbbVie | 1 | $30 |
| Immunitybio, Inc. | 1 | $29 |
| Hollister Incorporated | 2 | $24 |
| Blue Earth Diagnostics | 1 | $20 |
| Clarus Therapeutics Inc. | 3 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $18 |
| Dentsply IH AB | 1 | $15 |
| Cook Medical LLC | 1 | $13 |
| Travere Therapeutics, Inc. | 7 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$125
How this compares
$1,175 in reported general payments places this provider in the 30th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 71 | $72,129 |
| Tamsulosin Hcl | 835 | $18,477 |
| GemtesaVibegron | 19 | $18,277 |
| Finasteride | 337 | $5,768 |
| Testosterone | 15 | $5,068 |
| Oxybutynin Chloride ErOxybutynin Chloride | 160 | $4,963 |
| Silodosin | 27 | $2,360 |
| NitrofurantoinNitrofurantoin Macrocrystal | 54 | $2,112 |
| Dutasteride | 21 | $967 |
| Ciprofloxacin Hcl | 155 | $589 |
| Doxazosin Mesylate | 12 | $525 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $493 |
| Levofloxacin | 49 | $313 |
| Cephalexin | 19 | $259 |
| Oxybutynin Chloride | 20 | $214 |
Paid to pharmacies, not to this prescriber.
Other urology in Silver Spring
- Melissa MendezSilver Spring$61K
- Anup VoraSilver Spring$58K
- Philip KoiSilver Spring$14K
- Matthew AllawayCumberland$20.6M
- Ronald TutroneBaltimore$18.1M
- Mohamad AllafBaltimore$7.1M
- Max KatesBaltimore$1000K
- Benjamin LowentrittBaltimore$994K
- Rian DicksteinHanover$750K
- Laura GiustoOwings Mills$628K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.